Similar Search Results

Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark ; conference paper

Kaiser, Ulrich; Méndez, Susan; Rønde, Thomas; … - 2013 - This version: February 23, 2013

Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...

Persistent link: https://www.econbiz.de/10010339324

Price Cap Regulation in the Colombian Pharmaceutical Market : An Impact Evaluation

Bardey, David; Harker, Arturo; Zuluaga, Daniela - 2021

We evaluate the impact of a price cap regulation implemented in the Colombian pharmaceutical market between 2011 and … after regulation) for the eighteen ATC groups. A triple differences model with fixed time effects and cluster errors is used … to identify the impact of this regulation. We find that the price-cap regulation contributed to reduce prices in three of …

Persistent link: https://www.econbiz.de/10013238087

What drives innovation? : lessons from COVID-19 R&D

Agarwal, Ruchir; Gaulé, Patrick - 2021

To examine the drivers of innovation, this paper studies the global R&D effort to fight the deadliest diseases and presents four results. We find: (1) global pharmaceutical R&D activity - measured by clinical trials - typically follows the 'law of diminishing efforts': i.e. the elasticity of R&D...

Persistent link: https://www.econbiz.de/10012430944

Pharmaceutical prices under regulation : tiered co-payments and reference pricing in Germany

Herr, Annika; Suppliet, Moritz - 2012

Many countries with national health care providers and health insurances regulate the market for pharmaceuticals to … (no. of firms) suggests a significant but small negative correlation with prices. -- pharmaceuticals ; prices ; co …-payments ; reference pricing ; regulation ; firm behavior …

Persistent link: https://www.econbiz.de/10009522774

Do-it-Yourself Medicine? The Impact of Light Cannabis Liberalization on Prescription Drugs

Carrieri, Vincenzo - 2020

Governments worldwide are increasingly concerned about the booming CBD (cannabidiol) products. However, little is known about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using...

Persistent link: https://www.econbiz.de/10012839052

The Affordable Care Act and the Pharmaceutical Market : Projections from Institutional History

Daemmrich, Arthur A. - 2013

Fiercely contested before, during, and after its passage, the 2010 Patient Protection and Affordable Care Act (ACA) is beginning to restructure the U.S. healthcare market. This article describes the history of healthcare reform initiatives in the United States, analyzes the policy context in...

Persistent link: https://www.econbiz.de/10014151937

The Impact of Pharmaceutical Policy Measures : A Structural-Break Approach

Barros, Pedro P.; Nunes, Luis C. - 2009

Pharmaceutical spending in many other countries has had a steep increase in the last decade. The Portuguese Government has adopted several measures to reduce pharmaceutical expenditure growth, ranging from increased co-payments to price decreases determined administratively. Promotion of generic...

Persistent link: https://www.econbiz.de/10014209702

IP Nationalism : Addressing the COVID Crisis and Beyond

Ho, Cynthia M. - 2021

This Article coins and explains the phenomena of IP nationalism. Just as some nations engage in vaccine nationalism by hoarding limited COVID vaccines, so, too, some nations are hoarding critical knowledge and technology by resisting modification of usual IP rules during the pandemic, such as a...

Persistent link: https://www.econbiz.de/10013214965

Regulators Could Allow Early Use of COVID-19 Vaccine or Treatment

Yeoh, Ben - 2020

percent, efficacy can still be tested in real-world settings by adopting an approach that allows patients to begin drug …

Persistent link: https://www.econbiz.de/10014100167

Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark

Kaiser, Ulrich; Méndez, Susan J.; Rønde, Thomas; … - In: Journal of health economics 36 (2014), pp. 174-187

Persistent link: https://www.econbiz.de/10010483181

1
2
3
4
5
6
7
8
9
10
Next
Last